Related Experiment Videos

Decreased Na,K-ATPase gene expression in cardiomyopathic hamster hearts

Y Tsuruya1, U Ikeda, K Yamamoto

  • 1Department of Cardiology, Jichi Medical School, Tochigi, Japan.

Life Sciences
|January 1, 1994
PubMed

Insights

Sodium-potassium ATPase (Na,K-ATPase) mRNA and activity are significantly reduced in cardiomyopathic hamster hearts before disease onset. This suggests altered Na,K-ATPase gene expression is an early factor in cardiomyopathy development.

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Genetics

Background:

  • Cardiomyopathy involves heart muscle dysfunction.
  • Na,K-ATPase is crucial for maintaining cardiac cell function.
  • Altered gene expression may precede cardiac pathology.

Purpose of the Study:

  • To investigate Na,K-ATPase mRNA expression and activity in a hamster model of cardiomyopathy.
  • To determine if changes in Na,K-ATPase occur early in the disease process.

Main Methods:

  • Northern blot analysis to detect Na,K-ATPase mRNA isoforms (alpha 1, 2, 3, beta 1).
  • Quantitative analysis of alpha 1 subunit mRNA levels at 3 and 30 weeks.
  • Enzyme activity assays on ventricular membrane fractions.

Main Results:

  • Na,K-ATPase alpha 1, 2, 3, and beta 1 mRNAs were detected in both cardiomyopathic (Bio 14.6) and normal (F1b) hamsters.
  • Alpha 1 subunit mRNA levels were ~50% lower in Bio 14.6 hamsters at 3 and 30 weeks.
  • Na,K-ATPase activity was ~20% lower in 3-week-old Bio 14.6 hamsters.

Conclusions:

  • Significantly decreased Na,K-ATPase mRNA expression and activity observed in Bio 14.6 hamsters prior to hypertrophy.
  • Altered Na,K-ATPase gene expression is an early event in cardiomyopathy pathogenesis in this model.

Related Concept Videos